A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)
Clinical trial NCT05240612 · COMPLETED
Trial details
- NCT number
- NCT05240612
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2023-09-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.